OSCR Oscar Health
- 18.420
- +0.400+2.22%
Oscar Health News
10 Best Healthcare Stocks to Buy Under $20
With 58% Ownership in Oscar Health, Inc. (NYSE:OSCR), Institutional Investors Have a Lot Riding on the Business
Key Insights Significantly high institutional ownership implies Oscar Health's stock price is sensitive to their trading actions A total of 10 investors have a majority stake in the company with 50%
Oscar Health, Inc. to Host 2024 Investor Day
Oscar Health, Inc. ("Oscar" or the "Company") (NYSE:OSCR), a leading healthcare technology company, will host its 2024 Investor Day on Friday, June 7, 2024 in New York City. Management will discuss the Company's
When Can We Expect A Profit From Oscar Health, Inc. (NYSE:OSCR)?
Press Release: Oscar Health, Inc. 2024 First Quarter Conference Call
Oscar Health, Inc. 2024 First Quarter Conference Call NEW YORK--(BUSINESS WIRE)--April 02, 2024-- Oscar Health, Inc. ("Oscar") (NYSE: OSCR), a leading healthcare technology company, will release its
South Beach Detox Now Accepts Oscar Health Insurance to Reach More Patients
MIAMI, FL / ACCESSWIRE / March 28, 2024 / South Beach Detox, a leading Florida treatment facility, has announced that it now accepts Oscar health insurance policies. The move aligns with the rehab cen
Oscar Health Initiated at Outperform by Raymond James
Oscar Health Initiated at Outperform by Raymond James
Raymond James Initiates Coverage On Oscar Health With Outperform Rating, Announces Price Target of $20
Raymond James analyst John Ransom initiates coverage on Oscar Health (NYSE:OSCR) with a Outperform rating and announces Price Target of $20.
Loss-Making Oscar Health, Inc. (NYSE:OSCR) Expected To Breakeven In The Medium-Term
We feel now is a pretty good time to analyse Oscar Health, Inc.'s (NYSE:OSCR) business as it appears the company may be on the cusp of a considerable accomplishment. Oscar Health, Inc. operates as a
Oscar Health Insider Sold Shares Worth $381,847, According to a Recent SEC Filing
Richard Scott Blackley, Chief Financial Officer, on March 05, 2024, sold 27,043 shares in Oscar Health (OSCR) for $381,847. Following the Form 4 filing with the SEC, Blackley has control over a total
Oscar Health Insider Sold Shares Worth $252,937, According to a Recent SEC Filing
Alessandrea C. Quane, Executive Vice President, Chief Insurance Officer, on March 01, 2024, sold 15,928 shares in Oscar Health (OSCR) for $252,937.
Oscar Health (OSCR) Appreciated 270% in 2023
Longleaf Partners, managed by Southeastern Asset Management, released its “Small-Cap Fund” fourth-quarter 2023 investor letter.
Oscar Health(OSCR.US) Officer Sells US$991.1K in Common Stocks
$Oscar Health(OSCR.US)$ Officer Quane Alessandrea C. sold 55,000 shares of Common Stocks on Feb 16, 2024 at an average price of $18.02 for a total value of $991.1K.Source: Announcement What is stateme
Oscar Health(OSCR.US) Officer Sells US$772.86K in Common Stocks
$Oscar Health(OSCR.US)$ Officer Bopitiya Ranmali sold 42,865 shares of Common Stocks on Feb 16, 2024 at an average price of $18.03 for a total value of $772.86K.Source: Announcement What is statement
Oscar Health Insider Sold Shares Worth $772,856, According to a Recent SEC Filing
Ranmali Bopitiya, Executive Vice President & Chief Legal Officer, on February 16, 2024, sold 42,865 shares in Oscar Health (OSCR) for $772,856. Following the Form 4 filing with the SEC, Bopitiya has c
13 Best Booming Stocks to Buy Right Now
Oscar Health, Inc. (NYSE:OSCR) Analysts Are Pretty Bullish On The Stock After Recent Results
As you might know, Oscar Health, Inc. (NYSE:OSCR) recently reported its annual numbers. Revenue hit US$5.9b in line with forecasts, although the company reported a statutory loss per share of U
Oscar Health Is Maintained at Overweight by Wells Fargo
Oscar Health Is Maintained at Overweight by Wells Fargo
Oscar Health Price Target Raised to $20.00/Share From $12.00 by Wells Fargo
Oscar Health Price Target Raised to $20.00/Share From $12.00 by Wells Fargo
Buy Rating on Oscar Health With Revised $20 Price Target Amid Positive Financial Outlook
Analysis
Price Target
No Data
